Literature DB >> 21799331

Informatics in action: lessons learned in comparative effectiveness research.

Bradford R Hirsch1, Robert B Giffin, Laura C Esmail, Sean R Tunis, Amy P Abernethy, Sharon B Murphy.   

Abstract

Comparative effectiveness research (CER) is meant to provide evidence about the relative risks and benefits of different treatment options. It is gaining visibility as a tool to address the evidence gaps that clinicians struggle with every day; however, CER is particularly challenging in oncology as there is great variability in how individuals respond to interventions, and a wide range of drugs and procedures are available. In order to overcome these obstacles and conduct reliable CER studies, it is critical to create a robust data infrastructure to support it.The Center for Medical Technology Policy held its first annual CER Summit in November 2010, with a particular focus on oncology. A number of critical informatics themes emerged including the need for consistent data standards, registry reform, tools to assist trial accrual, and data to integrate into value deliberations. Addressing the data issues highlighted in this report will provide a significant opportunity to improve the health of our medical system.

Mesh:

Year:  2011        PMID: 21799331     DOI: 10.1097/PPO.0b013e31822c3944

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  7 in total

1.  Quality of life in higher resolution: the next generation of comparative effectiveness research in malignant hematology.

Authors:  Thomas W LeBlanc; Amy P Abernethy
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

2.  Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practice.

Authors:  Bradford R Hirsch; Michael R Harrison; Daniel J George; Mark S Walker; Connie Chen; Beata Korytowsky; Edward Stepanski; Amy P Abernethy
Journal:  Med Oncol       Date:  2014-08-14       Impact factor: 3.064

3.  How to improve breast cancer care measurement and reporting: suggestions from a complex urban hospital.

Authors:  Ann Scheck McAlearney; Jill Wellner; Nina A Bickell
Journal:  J Healthc Manag       Date:  2013 May-Jun

4.  A framework for understanding cancer comparative effectiveness research data needs.

Authors:  William R Carpenter; Anne-Marie Meyer; Amy P Abernethy; Til Stürmer; Michael R Kosorok
Journal:  J Clin Epidemiol       Date:  2012-11       Impact factor: 6.437

5.  Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for comparative effectiveness research.

Authors:  Sarah J Lowry; Elizabeth T Loggers; Erin J A Bowles; Edward H Wagner
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

6.  Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for CER.

Authors:  Sarah J Lowry; Elizabeth T Loggers; Erin J A Bowles; Edward H Wagner
Journal:  Am J Manag Care       Date:  2012-05       Impact factor: 2.229

7.  Recommendations for the use of operational electronic health record data in comparative effectiveness research.

Authors:  William R Hersh; James Cimino; Philip R O Payne; Peter Embi; Judith Logan; Mark Weiner; Elmer V Bernstam; Harold Lehmann; George Hripcsak; Timothy Hartzog; Joel Saltz
Journal:  EGEMS (Wash DC)       Date:  2013-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.